$Moderna (MRNA.US)$ Bullish on $MRNA. They’ve estimated that...

$Moderna(MRNA.US)$ Bullish on $MRNA. They’ve estimated that they’ll make $17-22B from the COVID vaccine next year with upside… this year it’ll be around $18B according to guidance.

And apart from the COVID vaccines, they have a good pipeline in general. CMV vaccine in phase 3 studies. Vaccine has zero competition the market is worth $20B. This is only the beginning of mRNA tech and $MRNA is a clear leader in terms of technology.